Large multimodal models jump from roughly 60% to 80% accuracy on neuroradiology cases when answer choices are provided.
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch lung biopsy robot.
Japanese bio-AI startup Craif banks $33M to push its urine-based pancreatic cancer test toward US launch.
An AI classifier trained on eye-movement data may spot amblyopia in patients who cannot complete standard vision tests.
The FDA fast-tracked Freenome's AI blood test for lung cancer, weeks after clearing its colorectal screen.
Mindful Care partners with NeuroKaire to offer an AI-driven blood test that predicts which antidepressant will work best for each…
The NHS COPD backlog of 600,000 patients drives TidalSense's $19M raise for its 75-second AI breath test that replaces century-old…
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.